PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1454104
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1454104
Serum Separation Gel Market size was valued at USD 7,476.23 Million in 2023, expanding at a CAGR of 6.8% from 2024 to 2032.
Serum separation gel is used in blood collection tubes to separate the blood clot from the serum before administering the blood test. There are two types of gel for blood samples: serum separation gel without integrated tubes and serum separation gel with integrated tubes.
Serum Separation Gel Market- Market Dynamics
Growing number of blood bank drives market growth
One of the main drivers of market expansion is the growth of blood banks around the world. The World Health Organization (WHO) 2023 reports that there are around 13,300 blood banks operating globally. Furthermore, according to the U.S. FDA Blood Establishment Registry, there were 53 community-based blood centers and 90 hospitals in the United States as of 2022. About 60% of the nation's blood supply is collected by these independent blood facilities, with the American Red Cross collecting roughly 40%. The process of gathering, preserving, and supplying blood pockets for blood transfusion to medical facilities and surgical centers has been greatly aided by blood banks. Blood serum is commonly extracted for laboratory testing using blood sample tubes with a separating gel. Thus, this is expected to drive the market growth.
Serum Separation Gel Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.8% over the forecast period (2024-2032)
Based on product type segmentation, the Serum Separation Gel Integrated with Tube segment is expected to hold a substantial market share during the forecast period
Based on end user segmentation, the Blood Bank segment is expected to hold the largest market share during the forecast period
Based on region, North America held the largest market share in 2023
The Global Serum Separation Gel Market is segmented based on Product Type, End User and Region.
The market is divided into four categories based on product type: Serum Separation Gel without Tubes and Serum Separation Gel Integrated with Tube. The Serum Separation Gel Integrated with Tube segment is expected to hold a substantial market share during the forecast period. This is explained by an increase in the use of these tubes for pathological clinical research to control the rising global burden of infectious disease. Enhanced sample handling and ease of use might lead to a rise in the need for these tubes and their wider application. The benefits of the category, which include enhanced radiation resistance, reduced interference with clinical test results, and others, are also expected to drive its growth.
The market is divided into five categories based on end user: Pharmaceutical & Biotechnology Companies, Hospital, Blood Bank and Others. The Blood Bank segment is expected to hold the largest market share during the forecast period. This is explained by the growing use of blood and its constituents-platelets, red blood cells (RBCC), white blood cells (WBC), and plasma-for medicinal reasons.
Serum Separation Gel Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to hold the largest market share during the forecast period. One of the main causes of this region's domination is a dramatic increase in the instances of hematological illnesses and infectious diseases. Due to significant comorbidities and weakened immune systems, the older group accounted for the majority of cases recorded. The market is growing since there are more blood banks with state-of-the-art facilities and easily accessible co-pay programs.
The key players operating in the market are Danaher, Deltalab, Greiner Bio-One International Gmbh, Sekisui Diagnostics, Hunan Liuyang Medical Instrument Factory, Bio-Rad Laboratories, Inc., Cardinal Health, Becton Dickinson & Company, IntervacTechnology and Biosigma S.p.A. These players adopted various types of strategies to remain competitive in the market such as product launches, acquisitions, expansion, approvals, agreements and others.
In September 2022, Amplifine Platelet Rich Plasma (PRP) gel tubes were introduced by Suneva Medical, Inc. to give patients and healthcare practices access to a sufficient quantity of PRP to better address various conditions. Furthermore, earlier that year, the U.S. FDA granted it clearance.
GLOBAL SERUM SEPARATION GEL MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Danaher
Deltalab
Greiner Bio-One International Gmbh
Sekisui Diagnostics
Hunan Liuyang Medical Instrument Factory
Bio-Rad Laboratories, Inc.
Cardinal Health
Becton Dickinson & Company
IntervacTechnology
Biosigma S.p.A.